You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RIC regimen; MDS; haplo-HSCT; survival

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • +3 more
  • Venetoclax plus RIC
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Oct 12, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Acute Leukemia, MDS Trial in Beijing (Cytarabine)

Recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking University, Institute of Hematolgoy
Sep 23, 2020

Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

Not yet recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 5, 2023

    GVHD Trial (Grafalon, Thymoglobulin)

    Not yet recruiting
    • GVHD
    • (no location specified)
    Oct 9, 2023

    Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

    Recruiting
    • Stem Cell Transplant Complications
    • +4 more
    • Radiation
    • +7 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 19, 2023

    Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

    Recruiting
    • Leukemia
    • +2 more
    • applying of FLU+CY post-HSCT
    • Guangzhou, Guangdong, China
      Nanfang Hospital
    Nov 23, 2023

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

    Recruiting
    • Hematopoietic Malignancy
    • +2 more
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Nov 6, 2023

    Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Suzhou (Individual ATG, ATG)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Acute Leukemia
    • Individual ATG
    • ATG
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 12, 2022

    Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

    Recruiting
    • Hematologic Malignancies
    • Haplo HCT <55 years old
    • +4 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 25, 2023

    Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Fludarabine, busulfan and melphalan
    • Fludarabine and Busulfan
    • Fuzhou, Fujian, China
    • +8 more
    Aug 14, 2023

    Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

    Recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Granulocyte Colony-Stimulating Factor(G-CSF)
    • +5 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jul 11, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

    Not yet recruiting
    • Acute Myelogenous Leukemia
    • +17 more
    • Peripheral Blood Stem Cell Transplant
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Mar 27, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (haplo-identical cells (donor), umbilical cord blood unit

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • haplo-identical cells (donor)
    • umbilical cord blood unit (CBU)
    • New York, New York
      Weill Cornell Medical College
    Dec 14, 2022

    The Optimization of Haploidentical Hematopoietic Stem Cell

    Not yet recruiting
    • Hematological Malignancy
    • ATG
    • Post-transplantation cyclophosphamide
    • Beijing, Beijing, China
      People's Hospital of Peking University
    Nov 28, 2022

    Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

    Recruiting
    • Primary Immune Deficiency Disorder
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University
    Oct 20, 2022

    AML/MDS Trial in Copenhagen (iDLI)

    Recruiting
    • AML/MDS
    • iDLI
    • Copenhagen, Denmark
      Copenhagen University Hospital, Rigshospitalet
    Jan 13, 2023

    Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

    Not yet recruiting
    • Hematological Malignancies
    • Allogeneic T cell progenitors, cultured ex-vivo
    • (no location specified)
    Mar 2, 2023

    Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

    Recruiting
    • Severe Aplastic Anemia (SAA)
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

    Completed
    • Acute Myelogenous Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 4, 2023

    Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

    Recruiting
    • Acute Leukemia
    • mitoxantrone liposome
    • ATG
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Feb 13, 2023

    Hematologic Malignancy Trial (Cyclophosphamid, ATG)

    Not yet recruiting
    • Hematologic Malignancy
    • (no location specified)
    Oct 29, 2023

    Allogenic Stem Cell Transplantation Trial (SAR445419)

    Not yet recruiting
    • Allogenic Stem Cell Transplantation
    • (no location specified)
    Feb 13, 2023